Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | XBP1 | P17861 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21563386 | 0.73 | PAX8 (0.50) | PAX8PTGS2MAPTRAB9ANPC1 | |
| Damsin SCHEMBL18642932 | 0.73 | PTGS2 (0.55) | PAX8PTGS2MAPTRAB9ANPC1 | |
| Damsin SCHEMBL18642934 | 0.73 | PTGS2 (0.55) | PAX8PTGS2MAPTRAB9ANPC1 | |
| SCHEMBL18550778 | 0.70 | PAX8 (0.47) | PAX8PTGS2MAPTRAB9ANPC1 | |
| SCHEMBL28044817 | 0.68 | PTGS2 (0.59) | PTGS2MAPTRAB9ANPC1XBP1 | |
| SCHEMBL31626700 | 0.68 | PTGS2 (0.59) | PTGS2MAPTRAB9ANPC1XBP1 | |
| Ambrosin SCHEMBL3463664 | 0.66 | MAPT (0.54) | PAX8PTGS2MAPTRAB9ANPC1 | |
| Ambrosin SCHEMBL3463663 | 0.66 | MAPT (0.54) | PAX8PTGS2MAPTRAB9ANPC1 | |
| SCHEMBL4067330 | 0.64 | PAX8 (0.61) | PAX8PTGS2MAPTRAB9APKM | |
| Pseudoguaianolide SCHEMBL31387995 | 0.62 | PTGS2 (0.55) | PTGS2MAPTRAB9ANPC1XBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103446-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | UNIV CALIFORNIA (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4382559-B1 | BIOACTIVE NANOCOMPOSITE FILM OF THERMOPLASTIC STARCH, BACTERIAL CELLULOSE AND GALLIC ACID AND ITS USES | RAIZ INSTITUTO DE INVESTIG DA FLORESTA E PAPEL (PT) | 2026-02-18 | — | — | EP | disclosed |
| EP-4019501-B1 | CFTR REGULATORS AND METHODS OF USE THEREOF | UNIV CALIFORNIA (US) | 2026-02-04 | — | — | EP | disclosed |
| US-20250391228-A1 | ANIMATING GAMING-TABLE OUTCOME INDICATORS FOR DETECTED RANDOMIZING-GAME-OBJECT STATES | LNW GAMING INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12503447-B2 | CFTR regulators and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-23 | — | — | US | disclosed |
| US-12472054-B2 | Inductive matrix for functional ocular surface reconstruction | ALVARADO CARLOS A (GT) | 2025-11-18 | — | — | US | disclosed |
| US-20250336256-A1 | ENHANCED TRACKING OF GAME ELEMENTS AT A GAMING TABLE | LNW GAMING, INC. | 2025-10-30 | — | — | US | disclosed |
| US-20250336257-A1 | PRE-EMPTIVELY MANAGING GAMING TABLE OUTCOMES | LNW GAMING, INC. | 2025-10-30 | — | — | US | disclosed |
| US-12391654-B2 | CFTR regulators and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-08-19 | — | — | US | disclosed |
| WO-2022077007-A1 | MOTIF NEOEPITOPES FOR CANCER IMMUNOTHERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-14 | — | — | WO | disclosed |
| US-20220081402-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-03-17 | — | — | US | disclosed |
| CN-110015962-B | Stilbene analogs and methods of treating cancer | 肯塔基大学研究基金会 | 2022-03-15 | — | — | CN | disclosed |
| EP-3394046-B1 | CFTR REGULATORS AND METHODS OF USE THEREOF | UNIV CALIFORNIA (US) | 2022-03-09 | — | — | EP | disclosed |
| CN-109476655-B | Carbonic anhydrase IX-targeted nuclear imaging and radiotherapy agents and uses thereof | 约翰霍普金斯大学 | 2022-03-08 | — | — | CN | disclosed |
| EP-3955869-A1 | DEVICES AND METHODS FOR LASER SURGERY OF AN EYE, ESPECIALLY FOR KERATOPLASTY | Carl Zeiss Meditec AG (DE) | 2022-02-23 | — | — | EP | disclosed |
| WO-2022027035-A1 | IN UTERO AND POSTNATAL GENE EDITING AND THERAPY FOR TREATMENT OF MONOGENIC DISEASES, INCLUDING MUCOPOLYSACCHARIDOSIS TYPE 1H AND OTHER DISORDERS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2022-02-03 | — | — | WO | disclosed |
| WO-2022020097-A1 | TRITURATION DEVICES FOR TISSUE DISAGGREGATION | PRIM SIGMA TECHNOLOGIES (US) | 2022-01-27 | — | — | WO | disclosed |
| US-20220025316-A1 | TRITURATION DEVICES FOR TISSUE DISAGGREGATION | PRIM SIGMA TECHNOLOGIES, INC. | 2022-01-27 | — | — | US | disclosed |
| US-11230535-B2 | CFTR regulators and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220081402-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | CFTR, SLC26A4, CLCN2 | PAX8 2403/4885PTGS2 1280/4885MAPT 4825/4885 |
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | AHCY, MACO1, ME3 | PAX8 4785/4885PTGS2 3699/4885MAPT 2120/4885 |
| US-11230535-B2 | CFTR regulators and methods of use thereof | CFTR, SLC26A4, CLCN2 | PAX8 2403/4885PTGS2 1280/4885MAPT 4825/4885 |
| US-20250391228-A1 | ANIMATING GAMING-TABLE OUTCOME INDICATORS FOR DETECTED RANDOMIZING-GAME-OBJECT STATES | COG2, COG3, COG1 | PAX8 1573/4885PTGS2 4007/4885MAPT 2267/4885 |
| US-12391654-B2 | CFTR regulators and methods of use thereof | CFTR, SLC26A4, CLCN2 | PAX8 2403/4885PTGS2 1280/4885MAPT 4825/4885 |
| US-20260103446-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | CFTR, CLCN2, SLC26A3 | PAX8 2434/4885PTGS2 1033/4885MAPT 4468/4885 |
| US-12503447-B2 | CFTR regulators and methods of use thereof | CFTR, SLC26A4, CLCN2 | PAX8 2403/4885PTGS2 1280/4885MAPT 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.